Clinical trials: Over Active Bladder
Over-Active Bladder
VESIcare For Improving OAB Symptoms in Patients Undergoing IGRT of the Prostate
The purpose of this study is to determine if Vesicare (Solifenacin succinate) is effective in treating over-active bladder symptoms during radiation therapy of the prostate.
- Trial name
- NCT01777217
- Testing
- Solifenacin succinate
- Where
- United States
- Volunteers
- 8 people, healthy volunteers welcome
- Sponsor
- Advanced Research Network
Over Active Bladder
Post Marketing Surveillance Of Fesoterodine In Filipino Patients With Over Active Bladder
This is an observational study and will determine the safety profile of fesoterodine in Filipino patients prescribed the drug. This is in compliance with the requirements of the Philippine Food and Drug Administration.
- Trial name
- NCT01260311
- Testing
- Fesoterodine
- Where
- 37 sites in Philippines
- Volunteers
- 508 people
- Sponsor
- Pfizer